Tesomet is an investigational fixed-dose combination therapy of tesofensine, a triple monoamine reuptake inhibitor, and metoprolol, a beta-1 selective blocker.
Investigators assess the efficacy of dietary supplements and alternative therapies for weight loss.
Digital self-monitoring of physical activity and diet is an effective intervention to support weight loss in adults with obesity or overweight.
The purpose of the updated statement stems from NAPNAP’s commitment to encouraging healthy lifestyles to establish a foundation of optimal health.
Researchers investigated the underlying mechanisms responsible for insulin resistance in patients with obesity and NAFLD.
Obesity in men with metastatic castration-resistant prostate cancer is associated with decreased risks for all-cause and cancer-specific mortality compared with overweight and normal-weight men.
A team of UK-based investigators explored the long-term cardiovascular outcomes in patients with obesity who were administered orlistat therapy.
Moderate and severe obesity is associated with a greater risk for postacute sequelae of COVID-19.
For individuals with class 1 obesity, bariatric surgery is effective for weight loss and comorbidity resolution.
“Metabolically healthy obesity” is associated with an increased risk for obesity-related outcomes, including incident diabetes, ASCVD, and heart failure compared with metabolically healthy individuals without obesity.
Investigators identified body mass index cutoffs for obesity based on the risk of developing type 2 diabetes among adults from different ethnic populations.